Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Pleural Effusion, Malignant × Doxycycline × Clear all

Phase

Phase NA 1 Phase 4 1 Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasm Metastasis 2 Triple Negative Breast Neoplasms 1 Pleural Effusion, Malignant 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms 1 Mycosis Fungoides 1 Lymphoma 1 Colonic Neoplasms 1 Breast Neoplasms 1 Brain Neoplasms 1

Interventions

Talc 5 Cisplatin 2 viscum album peptide 1 Thoracoscopy 1 Povidone-Iodine 1 Doxycycline 1 Bleomycin 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00002872 2023-06-22

Bleomycin, Doxycycline, or Talc in Treating Patients With Malignant Pleural Effusions

Eastern Cooperative Oncology Group

Phase 3 Completed

Neoplasm Metastasis, Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡